文献速递生殖医学

SARS-CoV-2 mRNA疫苗接种对不孕女性AMH浓度的影响

The effect of SARS-CoV-2 mRNA vaccination on AMH concentrations in infertile women.
PubMed 文献 · Reprod Biomed Online · 2022-06-22

这项前瞻性观察研究纳入31例接受IVF/ICSI的不孕女性,比较接种两剂SARS-CoV-2 mRNA疫苗前后血清AMH浓度,结果显示接种前后中位AMH浓度无显著差异(1.7 vs 1.6 ng/ml,P=0.96),且抗体滴度与AMH变化无相关性,结论认为mRNA疫苗接种不损害卵巢储备。

要点

  • 接种两剂SARS-CoV-2 mRNA疫苗前后中位AMH浓度无显著差异(1.7 vs 1.6 ng/ml,P=0.96)。
  • 参与者抗COVID-19抗体滴度与AMH浓度变化之间未发现相关性。
  • 研究结论认为SARS-CoV-2 mRNA疫苗接种不 adverse 影响卵巢储备,可作为临床咨询工具。

核心结论

  • SARS-CoV-2 mRNA疫苗接种不 adverse 影响卵巢储备,依据为接种前后血清AMH浓度的比较。
  • 这些发现可能作为临床咨询工具,用于向接受生育治疗女性保证SARS-CoV-2 mRNA疫苗接种是安全的。

研究设计与样本

  • 前瞻性观察研究,在单一大学附属IVF单位进行。
  • 纳入2020年11月至2021年9月期间接受IVF/卵胞浆内单精子注射、年龄18-44岁、已接种两剂SARS-CoV-2 mRNA疫苗、并在招募前12个月内测量过基线抗苗勒管激素(AMH)浓度的不孕女性。
  • 共纳入31名女性,评估并比较接种前后AMH浓度。

主要发现

  • 接种COVID-19疫苗前后中位AMH浓度相当(1.7 vs 1.6 ng/ml,P=0.96)。
  • 参与者抗COVID-19抗体滴度与AMH浓度变化之间未发现相关性。

临床怎么用

  • 作者认为这些发现可能作为临床咨询工具,向接受生育治疗女性保证SARS-CoV-2 mRNA疫苗接种是安全的。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does SARS-CoV-2 mRNA vaccination affect the ovarian reserve of infertile women undergoing IVF? DESIGN: This was a prospective observational study at a single university-affiliated IVF unit that included infertile women aged 18-44 years who were undergoing IVF/intracytoplasmic sperm injection between November 2020 and September 2021, had received two doses of SARS-CoV-2 mRNA vaccination and had undergone measurement of baseline anti-Müllerian hormone (AMH) concentration within the 12 months preceding their recruitment. AMH concentrations before and after vaccination were evaluated and compared. RESULTS: Overall, 31 women were included in the study. The median AMH concentrations before and after COVID-19 vaccine were comparable (1.7 versus 1.6 g/ml, respectively, P = 0.96). No correlation was found between the participant's anti-COVID-19 antibody titre and the change in AMH concentration. CONCLUSIONS: SARS-CoV-2 mRNA vaccination does not adversely affect ovarian reserve, as shown by comparing serum AMH concentrations before and after vaccination. These findings may serve as a counselling tool for clinicians to reassure women undergoing fertility treatment that SARS-CoV-2 mRNA vaccination is safe.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Horowitz E, Mizrachi Y, Ganer Herman H, et al. The effect of SARS-CoV-2 mRNA vaccination on AMH concentrations in infertile women. Reprod Biomed Online. 2022. PMID: 35985956. doi:10.1016/j.rbmo.2022.06.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。